These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 15608671
1. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci MW, Nemenoff RA. Oncogene; 2005 Feb 17; 24(8):1412-22. PubMed ID: 15608671 [Abstract] [Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG. J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072 [Abstract] [Full Text] [Related]
3. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Kim KY, Ahn JH, Cheon HG. Mol Pharmacol; 2007 Sep 01; 72(3):674-85. PubMed ID: 17535976 [Abstract] [Full Text] [Related]
4. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress. Kim HJ, Hwang JY, Kim HJ, Choi WS, Lee JH, Kim HJ, Chang KC, Nishinaka T, Yabe-Nishimura C, Seo HG. Clin Cancer Res; 2007 May 01; 13(9):2577-83. PubMed ID: 17473186 [Abstract] [Full Text] [Related]
5. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway. DeCicco KL, Tanaka T, Andreola F, De Luca LM. Carcinogenesis; 2004 Oct 01; 25(10):1805-12. PubMed ID: 15205358 [Abstract] [Full Text] [Related]
6. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094 [Abstract] [Full Text] [Related]
7. [Effect of DAPK1 gene transfection on high-metastasis non-small lung cancer cell PGCl3]. Zhang HT, Zhu ZY, Feng ZL, Li XY, Li MY, Ma JQ, Liang NC. Ai Zheng; 2004 May 05; 23(5):497-501. PubMed ID: 15142442 [Abstract] [Full Text] [Related]
8. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Inoue K, Kawahito Y, Tsubouchi Y, Yamada R, Kohno M, Hosokawa Y, Katoh D, Bishop-Bailey D, Hla T, Sano H. Anticancer Res; 2001 May 05; 21(4A):2471-6. PubMed ID: 11724309 [Abstract] [Full Text] [Related]
9. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T. Oncol Rep; 2005 Apr 05; 13(4):601-6. PubMed ID: 15756430 [Abstract] [Full Text] [Related]
10. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. Mol Carcinog; 2009 Jan 05; 48(1):24-37. PubMed ID: 18459128 [Abstract] [Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 05; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines. Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD. Anticancer Drugs; 2007 Jun 05; 18(5):525-34. PubMed ID: 17414621 [Abstract] [Full Text] [Related]
13. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. Zheng S, Chen A. Am J Physiol Gastrointest Liver Physiol; 2007 Jan 05; 292(1):G113-23. PubMed ID: 16959952 [Abstract] [Full Text] [Related]
14. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. Li M, Lee TW, Yim AP, Mok TS, Chen GG. J Cell Physiol; 2006 Nov 05; 209(2):428-38. PubMed ID: 16883598 [Abstract] [Full Text] [Related]
15. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L. Cancer Res; 2006 Jan 01; 66(1):18-23. PubMed ID: 16397209 [Abstract] [Full Text] [Related]
16. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu. Ren XL, Xu YM, Bao W, Fu HJ, Wu CG, Zhao Y, Li ZK, Zhang J, Li SQ, Chen WQ, Wang T, Zhang R, Zhang LH, Qian GS, Chen SY, Jia LT, Yang AG. Cancer Lett; 2009 Aug 28; 281(2):134-43. PubMed ID: 19339104 [Abstract] [Full Text] [Related]
17. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth. York M, Abdelrahim M, Chintharlapalli S, Lucero SD, Safe S. Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6743-52. PubMed ID: 18006776 [Abstract] [Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Han S, Roman J. Anticancer Drugs; 2007 Mar 15; 18(3):237-44. PubMed ID: 17264754 [Abstract] [Full Text] [Related]
19. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P. Crit Care Med; 2006 Jul 15; 34(7):1874-82. PubMed ID: 16715036 [Abstract] [Full Text] [Related]
20. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer. Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA. Mol Cancer Res; 2010 Jun 15; 8(6):833-43. PubMed ID: 20501643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]